Prenatal screening developments win UK accolade:
This article was originally published in Clinica
The development of prenatal screening of foetal abnormalities is the topic of the 2006 Healthcare Scientist of the Year award by the UK's Department of Health. It was presented at the Chief Scientific Officer's Conference, in London on November 27, to Professor Kevin Spencer (Barking, Havering & Redbridge Hospitals NHS Trust). The Association for Clinical Biochemistry underlined his "outstanding work in the development of a one-stop service for Down's screening".
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.